Table 2. Drug treatments in the two study arms.
| Active group (n = 44) |
Placebo group (n = 44) |
P | |
|---|---|---|---|
| ACE inhibitors (%) | 47.7% | 47.7% | 1.00 |
| Angiotensin Receptor Blockers (%) | 59.1% | 47.7% | 0.29 |
| Diuretics (%) | 34.1% | 47.7% | 0.19 |
| Alpha and Beta Blockers (%) | 36.4% | 38.6% | 0.83 |
| Calcium Antagonists (%) | 40.9% | 52.3% | 0.29 |
| Statins (%) | 45.5% | 52.5% | 0.52 |
| Omega 3 polyunsaturated fatty acids (%) | 27.3% | 11.4% | 0.06 |
| Hypoglycemizing agents (%) | 6.8% | 18.2 | 0.11 |
| Insulin (%) | 13.6% | 15.9% | 0.76 |
| Antiplatelet agents (%) | 50.0% | 54.5% | 0.83 |
| Nitrates (%) | 9.1% | 4.5% | 0.40 |
| Erythropoietin stimulating agents (%) | 2.3% | 2.0% | 0.56 |
| Iron (%) | 11.4% | 13.6% | 0.75 |
| Calcium carbonate (%) | 0.0% | 22.7% | 0.003 |
| Proton pump inhibitors (%) | 63.6% | 50.0% | 0.20 |
Data are expressed as percent frequency and compared by the Chi Square Test (with the continuity correction when appropriate).